- Home
- PHGE vs AEI Comparison
PHGE vs AEI Comparison
Compare PHGE & AEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHGE
- AEI
- Stock Information
- Founded
- PHGE 2015
- AEI 2014
- Country
- PHGE Israel
- AEI United States
- Employees
- PHGE N/A
- AEI N/A
- Industry
- PHGE Biotechnology: Pharmaceutical Preparations
- AEI Building operators
- Sector
- PHGE Health Care
- AEI Real Estate
- Exchange
- PHGE Nasdaq
- AEI Nasdaq
- Market Cap
- PHGE 13.3M
- AEI 11.2M
- IPO Year
- PHGE N/A
- AEI N/A
- Fundamental
- Price
- PHGE $0.59
- AEI $0.83
- Analyst Decision
- PHGE Strong Buy
- AEI
- Analyst Count
- PHGE 2
- AEI 0
- Target Price
- PHGE $23.00
- AEI N/A
- AVG Volume (30 Days)
- PHGE 184.4K
- AEI 43.8K
- Earning Date
- PHGE 05-19-2025
- AEI 05-14-2025
- Dividend Yield
- PHGE N/A
- AEI N/A
- EPS Growth
- PHGE N/A
- AEI N/A
- EPS
- PHGE N/A
- AEI N/A
- Revenue
- PHGE N/A
- AEI $21,115,899.00
- Revenue This Year
- PHGE N/A
- AEI N/A
- Revenue Next Year
- PHGE N/A
- AEI N/A
- P/E Ratio
- PHGE N/A
- AEI N/A
- Revenue Growth
- PHGE N/A
- AEI N/A
- 52 Week Low
- PHGE $0.48
- AEI $0.46
- 52 Week High
- PHGE $4.99
- AEI $2.61
- Technical
- Relative Strength Index (RSI)
- PHGE 46.36
- AEI 52.48
- Support Level
- PHGE $0.48
- AEI $0.89
- Resistance Level
- PHGE $0.70
- AEI $0.99
- Average True Range (ATR)
- PHGE 0.06
- AEI 0.06
- MACD
- PHGE 0.01
- AEI 0.01
- Stochastic Oscillator
- PHGE 50.54
- AEI 66.37
About PHGE BiomX Inc. COmmon Stock
BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.
About AEI Alset Inc. (TX)
Alset Inc is a diversified holding company engaged through its subsidiaries in the development of EHome communities and other real estate, financial services, digital transformation technologies, biohealth activities, and consumer products with operations in the United States, Singapore, Hong Kong, Australia, and South Korea. The Company operates in four business segments: real estate, digital transformation technology, Biohealth, and other business activities, and it derives a majority of its revenue from the Real Estate segment.